Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: A literature review

Menopause

Volumn 13, Issue 2, 2006, Pages 251-264

  Booth, Nancy L ^a   Piersen, Colleen E ^a   Banuvar, Suzanne ^b   Geller, Stacie E ^c,d   Shulman, Lee P ^b   Farnsworth, Norman R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Bone health; Botanical dietary supplement; Cardiovascular health; Menopause; Red clover; Trifolium pratense

Indexed keywords

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL PRODUCTS; BONE DENSITY; BREAST; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; FEMALE; GENISTEIN; HOT FLASHES; HUMANS; ISOFLAVONES; LIPIDS; MENOPAUSE; OSTEOPOROSIS, POSTMENOPAUSAL; PHYTOESTROGENS; PHYTOTHERAPY; PLANT PREPARATIONS; THYROID GLAND; TRIFOLIUM; VASOMOTOR SYSTEM;

EID: 33646772577     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000198297.40269.f7     Document Type: Review

References (87)

1. Baber RJ, Templeman C, Morton T, Kelly GE, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999;2:85-92.
2. Knight DC, Howes JB, Eden JA. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 1999;2:79-84.
3. Jeri AR. The use of an isoflavone supplement to relieve hot flushes. Female Patient 2002;27:47-49.
4. Nachtigall LB, La Grega L, Lee WW, Fenichel R, Nachtigall L. The effects of isoflavones derived from red clover on vasomotor symptoms and endometrial thickness. In: 9th International Menopause Society World Congress on the Menopause. Yokohama, Japan 1999.
5. van de Weijer PH, Barentsen R. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002;42:187-193.
6. Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR. Phytoestrogen supplements for the treatment of hot flashes: The isoflavone clover extract (ICE) study: a randomized controlled trial. JAMA 2003;290:207-214.
7. Atkinson C, Warren RM, Sala E, et al. Red clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial. Breast Cancer Res 2004;6:R170-R179.
8. Kelly GE, Husband AJ. Cardiovascular and bone treatment using isoflavones. PCT Int. Appl.: WO 00/64438, PCT/AU00/00384 2000.
9. Clifton-Bligh PB, Baber RJ, Fulcher GR, Nery ML, Moreton T. The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 2001;8:259-265.
10. Hale GE, Hughes CL, Robboy SJ, Agarwal SK, Bievre M. A double-blind randomized study on the effects of red clover isoflavones on the endometrium. Menopause 2001;8:338-346.
11. Atkinson C, Compston JE, Day NE, Dowsett M, Bingham SA. The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2004;79:326-333.
12. Schult TM, Ensrud KE, Blackwell T, Ettinger B, Wallace R, Tice JA. Effect of isoflavones on lipids and bone turnover markers in menopausal women. Maturitas 2004;48:209-218.
13. Nestel PJ, Pomeroy S, Kay S, et al. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab 1999;84:895-898.
14. Teede HJ, McGrath BP, DeSilva L, Cehun M, Fassoulakis A, Nestel PJ. Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women. Arterioscler Thromb Vasc Biol 2003;23:1066-1071.
15. Baber R, Clifton-Bligh P, Fulcher G, Liberman D, Nery L, Moreton T. The effect of an isoflavone dietary supplement (Rimostil) on serum lipids, forearm bone density and endometrial thickness in post-menopausal women. Presented at the 10th Annual Meeting of The North American Menopause Society, September 23-25, 1999, New York, 1999.
16. Howes JB, Sullivan D, Lai N, et al. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of postmenopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 2000;152:143-147.
17. Blakesmith SJ, Lyons-Wall PM, George C, Joannou GE, Petocz P, Samman S. Effects of supplementation with purified red clover (Trifolium pratense) isoflavones on plasma lipids and insulin resistance in healthy premenopausal women. Br J Nutr 2003;89:467-474.
18. Howes JB, Tran D, Brillante D, Howes LG. Effects of dietary supplementation with isoflavones from red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetes. Diabetes Obes Metab 2003;5:325-332.
19. Campbell MJ, Woodside JV, Honour JW, Morton MS, Leathem AJ. Effect of red clover-derived isoflavone supplementation on insulin-like growth factor, lipid and antioxidant status in healthy female volunteers: a pilot study. Eur J Clin Nutr 2004;58:173-179.
20. Nestel P, Cehun M, Chronopoulos A, DaSilva L, Teede H, McGrath B. A biochanin-enriched isoflavone from red clover lowers LDL cholesterol in men. Eur J Clin Nutr 2004;58:403-408.
21. Atkinson C, Oosthuizen W, Scollen S, Loktionov A, Day NE, Bingham SA. Modest protective effects of isoflavones from a red clover-derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, and evidence of an interaction with ApoE genotype in 49-65 year-old women. J Nutr 2004;134:1759-1764.
22. Coon N. Using Plants for Healing: An American Herbal. New York, NY: Hearthside Press; 1963:272.
23. Silverman M. A City Herbal: A Guide to the Lore, Legend and Usefulness of 34 Plants That Grow in the City. 1st ed. New York, NY: Knopf: distributed by Random House; 1977:181.
24. Bolyard JL. Medicinal Plants and Home Remedies of Appalachia. Springfield, IL: Thomas; 1981:187.
25. Hartwell JL. Plants Used Against Cancer: A Survey. Lawrence, MA: Quarterman Publications, Inc.; 1982:311-313.
26. Bennetts HW, Underwood EJ, Shier FL. A specific breeding problem of sheep on subterranean clover pastures in western Australia. Aust Vet J 1946;22:2-12.
27. Moule GR, Braden AWH, Lamond DR. The significance of oestrogens in pasture plants in relation to animal production. Anim Breed Abstr 1963;32:139-157.
28. Seddon HD. Detection of clover disease in wethers. Aust Vet J 1968;44:308-312.
29. Adams NR, Lightfoot RJ, Charlick AJ. The duration of the oestrous cycle of ewes affected with clover disease. Aust Vet J 1975;51:306-309.
30. Heydon RA, Adams NR. Histochemical studies on cervical glands in ewes with clover disease. J Comp Pathol 1977;87:353-361.
31. Nwannenna AI, Madej A, Lundh TJ, Fredriksson G. Effects of oestrogenic silage on some clinical and endocrinological parameters in ovariectomized heifers. Acta Vet Scand 1994;35:173-183.
32. Nwannenna AI, Lundh TJ, Madej A, Fredriksson G, Bjornhag G. Clinical changes in ovariectomized ewes exposed to phytoestrogens and 17 beta-estradiol implants. Proc Soc Exp Biol Med 1995;208:92-97.
33. Duke JA, Ayensu ES. Medicinal Plants of China. Algonac, MI: Reference Publications, Inc.; 1985: p. 52-361.
34. Hussey JS. Some useful plants of early New England. Econ Bot 1974;28:311-337.
35. Nebelkopf E. Herbs and cancer. Part II. Herbalist 1981;6:26-39.
36. Rios JL, Recio MC, Villar A. Antimicrobial activity of selected plants employed in the Spanish Mediterranean area. J Ethnopharmacol 1987;21:139-152.
37. Sezik E, Yesilada E, Tabata M, et al. Traditional medicine in Turkey. VIII. Folk medicine in East Anatolia: Erzurum, Erzincan, Agri, Kars, Igdir provinces. Econ Bot 1997;51:195-211.
38. Ulbricht C, Nelsen J, Barrette EP, et al. Red clover (Trifolium pratense) monograph: a clinical decision support tool. J Herb Pharmcother 2003;2:49-72.
39. Hamel PB, Chiltoskey MU. Cherokee Plants: Their Uses: A 400 Year History. Sylva, NC: Herald Publishing Company; 1975:29.
40. Herrick JW. Iroquois medical botany [Dissertation]. Albany, NY: The State University of New York at Albany; 1977.
41. Krag KJ. Plants used as contraceptives by the North American Indians: an ethnomedical study [BS thesis]. Cambridge, MA: Harvard University; 1976.
42. Felter HW, Lloyd JU. King's American Dispensatory. Vol. II. 18th ed. Cincinnati, OH: The Ohio Valley Company; 1900:1995-1996.
43. The National Formulary. 5th ed. United States of America: American Pharmaceutical Association; 1926.
44. Grieve MA. A Modern Herbal. New York, NY: Dover Publications; 1978:207-208.
45. De Bairacli Levy J. Common Herbs for Natural Health. New York, NY: Schocken Books; 1974:200.
46. Ossadcha-Janata N. Herbs used in Ukrainian folk medicine, Mimeographed series #21, Research program on the USSR and the NY Botanical Garden. New York, NY; 1952.
47. Ward PS. History of Hoxsey treatment. Townsend Letter for Doctors and Patients 1997;68-72.
48. Howes JB, Bray K, Lorenz L, Smerdely P, Howes LG. The effects of dietary supplementation with isoflavones from red clover on cognitive function in postmenopausal women. Climacteric 2004;7:70-77.
49. Piersen CE. Phytoestrogens in botanical dietary supplements: implications for cancer. Integr Cancer Ther 2003;2:120-138.
50. Reginster JY, Deroisy R, Fontaine MA, Franchimont P. Influence of estrogen replacement therapy on endogenous calcitonin production rates. Gynecol Endocrinol 1992;6:65-71.
51. Ham KD, Carlson CS. Effects of estrogen replacement therapy on bone turnover in subchondral bone and epiphyseal metaphyseal cancellous bone of ovariectomized Cynomolgus monkeys. J Bone Miner Res 2004;19:823-829.
52. Sornay-Rendu E, Garnero P, Munoz F, Duboeuf F, Delmas PD. Effect of withdrawal of hormone replacement therapy on bone mass and bone turnover: the OFELY study. Bone 2003;33:159-166.
53. Wu F, Ames R, Clearwater J, Evans MC, Gamble G, Reid IR. Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy. Clin Endocrinol 2002;56:703-711.
54. Choi JW, Pai SH. Bone mineral density correlates strongly with basal metabolic rate in postmenopausal women. Clin Chim Acta 2003;333:79-84.
55. Cifuentes M, Riedt CS, Brolin RE, Field MP, Sherrell RM, Shapses SA. Weight loss and calcium intake influence calcium absorption in overweight postmenopausal women. Am J Clin Nutr 2004;80:123-130.
56. Abrams SA. Normal acquisition and loss of bone mass. Hormone Res 2003;60(Supp 13):71-76.
57. Garcia-Martinez MC, Hermenegildo C, Tarin JJ, Cano A. Phytoestrogens increase the capacity of serum to stimulate prostacyclin release in human endothelial cells. Acta Obstet Gynecol Scand 2003;82:705-710.
58. Schiffrin EL. A critical review of the role of endothelial factors in the pathogenesis of hypertension. J Cardiovasc Pharmacol 2001;38(Suppl 2):S3-S6.
59. Simoncini T, Fornari L, Mannella P, et al. Activation of nitric oxide synthesis in human endothelial cells by red clover extracts. Menopause 2005;12:69-77.
60. Steiner G. Treating lipid abnormalities in patients with type 2 diabetes mellitus. Am J Cardiol 2001;88:37N-40N.
61. Kaukua J, Turpeinen A, Uusitupa M, Niskanen L. Clustering of cardiovascular risk factors in type 2 diabetes mellitus: Prognostic significance and tracking. Diabetes Obes Metab 2001;3:17-23.
62. Greendale GA, Reboussin BA, Sie A, et al. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal estrogen/progestin interventions (PEPI) investigators. Ann Intern Med 1999;130:262-269.
63. Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393-1396.
64. Ingram DM, Hickling C, West L, Mahe LJ, Dunbar PM. A double-blind randomized controlled trial of isoflavones in the treatment of cyclical mastalgia. Breast 2002;11:170-174.
65. Madej A, Persson E, Lundh T, Ridderstrale Y. Thyroid gland function in ovariectomized ewes exposed to phytoestrogens. J Chromatogr B 2002;777:281-287.
66. Adams NR. Morphological changes in the organs of ewes grazing oestrogenic subterranean clover. Res Vet Sci 1977;22:216-221.
67. Amer M, El-Habibi ES, El-Gendy A. Effects of Trifolium alexandrinum extracts on streptozotocin-induced diabetes in male rats. Ann Nutr Metab 2004;48:343-347.
68. Widyarini S, Spinks N, Reeve VE. Protective effect of isoflavone derivative against photocarcinogenesis in a mouse model. Redox Rep 2000;5:156-158.
69. Widyarini S, Spinks N, Husband AJ, Reeve VE. Isoflavonoid compounds from red clover (Trifolium pratense) protect from inflammation and immune suppression induced by UV radiation. Photochem Photobiol 2001;74:465-470.
70. Kroyer G, Hatzl C. Evaluation of isoflavones as functional bioactive phytochemicals in food. R Soc Chem 2001;269:495-497.
71. Georgetti SR, Casagrande R, Di Mambro VM, Azzolini AE, Fonseca MJ. Evaluation of the antioxidant activity of different flavonoids by the chemiluminescence method. AAPS Pharm Sci 2003;5:E20.
72. Kroyer GT. Red clover extract as antioxidant active and functional food ingredient. Innov Food Sci Emerg Technol 2004; 5:101-105.
73. Patel RP, Boersma BJ, Crawford JH, et al. Antioxidant mechanisms of isoflavones in lipid systems: paradoxical effects of peroxyl radical scavenging. Free Radic Biol Med 2001;31:1570-1581.
74. Smith M, Boon HS. Counseling cancer patients about herbal medicine. Patient Educ Couns 1999;38:109-120.
75. Standish LJ, Greene K, Greenlee H, Kim JG, Grosshans C. Complementary and alternative medical treatment of breast cancer: a survey of licensed North American naturopathic physicians. Altern Ther Health Med 2002;8:68-70;72-75.
76. Hoxsey method/bio-medical center. CA Cancer J Clin 1990;40:51-55.
77. Questionable methods of cancer management: 'nutritional' therapies. CA Cancer J Clin 1993;43:309-319.
78. LeMoine L. Essiac: an historical perspective. Can Oncol Nurs J 1997;7:216-221.
79. Kaegi E. Unconventional therapies for cancer: 1. Essiac. The task force on alternative therapies of the Canadian breast cancer research initiative. CMAJ 1998;158:897-902.
80. Tamayo C, Richardson MA, Diamond S, Skoda I. The chemistry and biological activity of herbs used in Flor-Essence herbal tonic and Essiac. Phytother Res 2000;14:1-14.
81. Bennett LM, Montgomery JL, Steinberg SM, Kulp KS. Flor-Essence herbal tonic does not inhibit mammary tumor development in Sprague-Dawley rats. Breast Cancer Res Treat 2004;88:87-93.
82. Schindler AE. Thyroid function and postmenopause. Gynecol Endocrinol 2003;17:79-85.
83. Doerge DR, Sheehan DM. Goitrogenic and estrogenic activity of soy isoflavones. Environ Health Perspect 2002;110:(Suppl 3)349-353.
84. Chan HY, Wang H, Leung LK. The red clover (Trifolium pratense) isoflavone biochanin A modulates the biotransformation pathways of 7,12-dimethylbenz[a] anthracene. Br J Nutr 2003;90:87-92.
85. Roberts DW, Doerge DR, Churchwell MI, Gamboa da Costa G, Marques MM, Tolleson WH. Inhibition of extrahepatic human cytochromes P450 1A1 and 1B1 by metabolism of isoflavones found in Trifolium pratense (red clover). J Agric Food Chem 2004;52:6623-6632.
86. Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom 2004;18:2273-2281.
87. McGuffin M, Hobbs C, Upton R, Goldberg A. American Herbal Products Association's Botanical Safety Handbook. New York, NY: CRC Press; 1997:117.